Our latest News & Events
What is the Requirement for Transparency of Conflicts of Interest with Healthcare Professionals in France?
Following the “Médiator” case and inspired by the Sunshine Act in the United States, the law of December 29, 2011, concerning the strengthening of health
Atessia supports its clients daily in the practical modalities of implementing the French early and compassionate access system, whose subtleties require some explanations. On July
From a legislative point of view, the mutual recognition procedure is defined by the Directive 2001/83/EC of the European Parliament and of the Council of
What about the classification of Marketing Authorization variations? When a holder wishes to register a medicine in a country, he submits a marketing authorization application
ATESSIA Life Science Advisors, a Catalyst for Regulatory Innovation: Collaborating with UBAQ, ATESSIA Sets a New Standard to Facilitate the Management of Regulatory Challenges in the Health Sector
An alliance capable of moving mountains. ATESSIA and UBAQ jointly pave the way for health sector players. The health sector, constantly evolving and in the
Law No. 2023-451 dated June 9, 2023, which aims to regulate commercial influence and combat abuses by influencers on social media platforms, not only defines
What are the possible interactions between health industry players and healthcare professionals (HCPs) in France?
Promotional visit for medicinal products in France refers to promotional interactions with healthcare professionals (HCPs) conducted by authorized collaborators from the pharmaceutical industry. The structural